Cannabis Testing market Professional Survey Report by 2035

Driven by the growing demand for medical and recreational cannabis, along with its increasing global legalization, a substantial number of product manufacturers are leveraging the expertise of testing service providers in this industry

Roots Analysis has announced the addition of “Cannabis Testing Market, 2023-2035” report to its list of offerings.

The report features an extensive study on the current landscape and the likely future potential of cannabis testing market over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report features:
 An executive summary of the insights captured during our research. It offers a high-level view on the current state of the cannabis testing market and its likely evolution in the mid-long term.
 A general introduction to cannabis testing, along with details related to the applications and needs for testing cannabis infused products. In addition, this section presents information on different types of testing protocols mandated by the regulatory authorities to ensure consumer safety. Further, it concludes with a discussion on the emerging trends in cannabis labs testing and future perspectives in this market.
 A detailed assessment of the overall market landscape of cannabis testing labs based on several relevant parameters, such as year of establishment, company size (in terms of employee count), location of headquarters, type of offering(s) (cannabis testing services or cannabis testing services & products), type of company (private company or public company), number of facilities (less than 5 facilities, 5 to 10 facilities, and more than 10 facilities), type of accreditation(s) / certification(s) (ISO, PJLA, DEA, A2LA, USDA, FDA, ELAP, AOAC, CDPHE, UKAS, NCIA, NELAP, DCC, ORELAP, HIA, CLIA, ANAB ANSI, and Others), number of accreditation(s) / certification(s) (less than 5 accreditations, 5-10 accreditations, and undisclosed), type of testing solution(s) offered (potency testing, terpenes testing, microbial analysis, pesticides testing, residual solvents testing, heavy metals testing, mycotoxins testing, moisture analysis, DNA genotyping, vitamin E acetate testing, and flavonoids testing), type of sample(s) tested (edibles and infused products, cannabis buds / flowers, cannabis extracts / concentrates, and cannabis oils), type of cannabis and hemp tested (by legal status - medical cannabis, hemp, recreational / adult-use cannabis, and others), and end-user(s) (cannabis cultivators / growers, cannabis drug / product manufacturers, cannabis edible manufacturers, and other research institutes).
 An insightful competitiveness analysis of cannabis testing labs based on company strength (in terms of years of experience), portfolio strength (in terms of type of company, number of facilities, type of offerings, number of testing solutions offered, number of samples tested, type of cannabis and hemp tested, and number of end-users) and number of accreditations / certifications.
 Elaborate profiles of key cannabis testing labs (shortlisted based on a proprietary criterion); each profile includes a brief overview of the company, along with information on its financial information (if available), service portfolio, recent developments and an informed future outlook.
 A detailed assessment of the overall market landscape of cannabis testing product providers, based on several relevant parameters, such as their year of establishment, company size (in terms of employee count), location of headquarters, type of offering(s) (cannabis testing products or cannabis testing services & products), type of testing product(s) offered (analytical instruments, consumables, reagents and additional software solutions), type of analytical instrument(s) offered (chromatography instruments, spectroscopy instruments and others), and type of additional software solution(s) offered (Laboratory Information Management System (LIMS), Customer Relationship Management (CRM), Enterprise Resource Planning (ERP)).
 A detailed analysis of the partnerships that have been inked within the cannabis testing market, since 2018, based on several relevant parameters, such as year of partnership, type of partnership (mergers and acquisitions, research and development agreements, service alliances, technology integration agreements, distribution agreements, licensing agreements and other agreements), type of partner (industry and non-industry), geographical location of the companies involved, and most active players (in terms of number of partnerships).
 An in-depth analysis of recent events (webinars / conferences / expos / summits) that were organized across different regions of the globe for stakeholders in this market, based on several relevant parameters, such as year of event, event platform, type of event, year and type of event, distribution of events by geography, evolutionary trends in event agenda / key focus area, most popular event organizers, most active industry players, most active non-industry players, most active speakers (in terms of number of events), details of the designation of speakers, affiliated department of event speakers and a geographical mapping of upcoming events.
 One of the key objectives of the report was to estimate the current opportunity and future growth potential of cannabis testing market over the coming years. We have provided informed estimates on the likely evolution of the market for the period, 2023-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of cannabis tested, type of sample tested, company size and key geographical regions. In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s evolution.

By 2035, financial opportunity within the cannabis testing market has been analyzed across the following segments:

 Type of Cannabis Tested
 Medical Cannabis
 Recreational / Adult-use Cannabis

 Type of Sample Tested
 Flowers
 Extracts
 Edibles
 Others

 Company Size
 Large
 Mid-sized
 Small

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa

Key companies covered in the report
 AccuScience Laboratories
 Anresco Labs
 CDX Analytics
 Coastal Analytical
 Eurofins Scientific
 EVIO Labs
 FoodChain ID
 LGC
 Medicine Creek Analytics
 SGS
 Tentamus

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/cannabis-tes

Learn from experts: do you know about these emerging industry trends?
Top 5 Companies Developing Bispecific Antibodies
Top 5 Digital Twin Companies in Healthcare industry

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Connect with our Roots Analysis Consulting team: For your custom research exclusive best-in-class quality projects

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#cannabistestingmarket#cannabistestingmarketsize #cannabistesting #cannabistestingmarket #marijuanatesting

Medical Device Coating market Professional Survey Report by 2035

Driven by the growing demand of medical devices, coupled with unique coating needs for each type of medical device, an increasing number of developers are leveraging the technical expertise of coating providers in this industry

Roots Analysis has announced the addition of “Medical Device Coating Market, 2023-2035” report to its list of offerings. The report features an extensive study on the current market landscape, offering an informed opinion on the likely adoption of medical coatings and surface modification technologies in the healthcare industry, in the mid to long term. The study underlines an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.

Amongst other elements, the report includes:
 A detailed executive summary of the insights captured during our research.
 A detailed assessment of the current market landscape of medical device coating providers.
 Detailed competitiveness analysis of various medical device coating providers.
 A detailed assessment of the overall market landscape of medical device surface modification technologies and coating solutions.
 Detailed product competitiveness analysis of the various surface modification technologies and coating solutions.
 Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering medical device coatings.
 An insightful analysis of the recent partnerships that have been inked within the surface modification technologies and coating solutions industry, since 2018.
 An insightful analysis of the leading medical device coating providers, considering the affiliated factors, key drivers, and challenges under the PESTLE framework.
 A detailed medical coatings market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

 Type of Devices Coated
 Class I Medical Devices
 Class II Medical Devices
 Class III Medical Devices

 Type of Coating Material
 Polymer Coatings
 Metal Coatings
 Other Coatings

 Company Size
 Very Small
 Small
 Mid-sized
 Large
 Very Large

 Key Geographical Region
 North America
 Europe
 Asia
 Rest of the World

Key companies covered in the report
 Advanced Coating
 Biocoat
 Evonik
 Formacoat
 Harland Medical Systems
 Para-Coat Technologies
 Specialty Coating Systems
 SurModics
 TUA Systems

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/medical-devi

Learn from experts: do you know about these emerging industry trends?
Introduction To Exosome Therapeutics
Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#medicaldevicecoatingmarket #medicaldevicecoatingmarketsize #medicaldevicecoating #medicalcoatingsmarket #medicalcoatingcompanies

Deep Learning in Drug Discovery market Professional Survey Report by 2035

Increased capital investments and higher attrition rates have prompted the implementation of deep learning technologies to expedite drug discovery process; early-stage diagnostic capability of such technologies has also emerged as a key driver for their adoption

Roots Analysis is pleased to announce the publication of its recent study, titled, “Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market (2nd Edition), 2023-2035”

report features an extensive study of the current market landscape and the likely future potential of the deep learning in healthcare domain. The report highlights the efforts of several stakeholders engaged in this rapidly emerging segment of the pharmaceutical industry. Amongst other elements, the report includes:
 An executive summary of the insights captured during our research, offering a high-level view on the current state of deep learning market for drug discovery and diagnostics and its likely evolution in the mid-to-long term.
 A general overview of big data revolution in the medical industry, along with information on artificial intelligence, machine learning and deep learning algorithms.
 A detailed assessment of the market landscape of more than 70 companies offering deep learning technology / services for the purpose of drug discovery, based on several relevant parameters.
 A detailed assessment of the market landscape of more than 130 companies offering deep learning technologies / services for diagnostics, based on several relevant parameters.
 Elaborate profiles of key players developing technologies and offering services related to deep learning, specifically for drug discovery and diagnostics.
 A qualitative analysis, highlighting the five competitive forces prevalent in the deep learning domain.
 An analysis of completed and ongoing clinical trials related to deep learning, based on several relevant parameters.
 A detailed analysis of various investments made by players engaged in this domain, during the period 2019-2022, based on several relevant parameters.
 An analysis of the start-ups / small players (established post 2015, with less than 50 employees) engaged in the deep learning market focused on drug discovery and diagnostics.
 An elaborate valuation analysis of companies that are involved in the deep learning in drug discovery and diagnostics market, based on our proprietary, multi-variable dependent valuation model to estimate the current valuation / net worth of deep learning industry players.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

 Therapeutic Area
 Oncological Disorders
 Infectious Diseases
 Neurological Disorders
 Immunological Disorders
 Endocrine Disorders
 Cardiovascular Disorders
 Respiratory Disorders
 Ophthalmic Disorders
 Musculoskeletal Disorders
 Other Disorders

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Rest of the World

Key companies / organizations covered in the report
 Aegicare
 Aiforia Technologies
 Ardigen
 Berg
 Google
 Huawei
 Merative
 Nference
 Nvidia
 Owkin
 Phenomic AI
 Pixel AI

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/view_documen

Learn from experts: do you know about these emerging industry trends?
Exploring How Artificial Intelligence Is Transforming Digital Pathology
At-home Self-testing: A Giant Leap Towards Transformation in Diagnostic Sector

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#deeplearningindrugdiscoverymarket #deeplearningindrugdiscoverymarketsize #deeplearningindustry #deeplearningtrends #deeplearningcompanies

Antibody Drug Conjugate market, Industry Analysis, and Forecast to 2035

The potential of antibody drug conjugates for the treatment of various disease indications, including cancer, is being slowly recognized in the pharmaceutical sector. Specifically, the success of these products can be attributed to their ability to effectively identify and eliminate diseased cells, along with low risk of side effects.

The financial opportunity within the antibody drug conjugate market has been analyzed across the following segments:

 Target Disease Indication
 Acute Lymphoblastic Leukemia
 Breast Cancer
 B-Cell Lymphoma
 Cervical Cancer
 Gastric Cancer
 Lung Cancer
 Multiple Myeloma
 Renal Cancer
 Other Target Disease Indications

 Therapeutic Area
 Hematological Cancer
 Solid Tumor

 Linker
 Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (Acbut)
 Maleimide
 Maleimidocaproyl
 Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate
 Tetrapeptide-Based Linker
 Valine-Alanine
 Valine-Citrulline
 Other Linkers

 Payload
 DM1
 DM4
 Duocarmycin
 Monomethyl auristatin E (MMAE)
 Monomethyl auristatin F (MMAF)
 Ozogamicin
 SG3199
 SN-38 / Irinotecan
 Other Payloads

 Target Antigen
 BCMA (TNFRSF17 / BCM)
 CD19
 CD22
 CD30
 CD79b
 CEACAM5
 HER-2 (ERBB2)
 Nectin 4
 Tissue factor
 TROP-2
 Other Target Antigen

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific and Rest of the World

The Antibody Drug Conjugate Market (7th Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:
 ADC Therapeutics
 Astellas Pharma
 AstraZeneca
 Byondis
 Daiichi Sankyo
 Genentech
 Gilead Sciences
 ImmunoGen
 Pfizer
 RemeGen

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Target Competitiveness Analysis

6. Company and Drug Profiles

7. Clinical Trial Analysis

8. Key Opinion Leaders

9. Combination Therapies

10. Partnerships and Collaborations

11. Funding and Investment Analysis

12. Patent Analysis

13. Academic Grants Analysis

14. Key Commercialization Strategies

15. Promotional Analysis

16. Success Protocol Analysis

17. Novel Conjugation and Linker Technology Platforms

18. Assessment of Non-Clinical Data First in Human Dosing

19. Cost Price Analysis

20. Case Study 1: Contract Manufacturing of Antibody-Drug Conjugates

21. Case Study 2: Companion Diagnostics for Antibody-Drug Conjugate Therapeutics

22. SWOT Analysis

23. Market Sizing and Opportunity Analysis

24. Executive Insights

25. Conclusion

26. Appendix 1: Tabulated Data

27. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/view_documen

Learn from experts: do you know about these emerging industry trends?
Digital Therapies: The “Digital Pills” of current generation
Medical Device Coatings and Modification Technologies

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#antibodydrugconjugatemarketshare #antibodydrugconjugatemarkettrends #antibodydrugconjugates #adctherapeutics #antibodydrugconjugatecompanies

Cell Free Expression market, Industry Analysis, and Forecast to 2035

Considering the benefits offered by cell free expression, including low cost of production, shortened production timelines and better control over the reaction environment, the adoption of cell free systems has increased over the years.

Driven by the ongoing pace of innovation and growing adoption of cell free systems in the production of biomolecules, the global cell free expression market is anticipated to grow at a healthy pace in the foreseen future.

The financial opportunity within the cell free market is analyzed across the following segments:

 Type of Cell Free System
 Crude Cell Lysate-based Systems
 Reconstituted Systems

 Type of Host Organism
 Microbial Cell Free Expression System
 Mammalian Cell Free Expression Systems
 Plant-based Cell Free Expression Systems
 Other Cell Free Expression Systems

 Type of Expression Method
 Coupled Transcription and Translation Method
 Translation Method

 End-User
 Pharmaceutical and Biotechnology Companies
 Academic and Research Institutes
 Other End-Users

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Rest of the World

The Cell Free Systems: Cell Free Expression Kits and Service Providers, 2023-2035 report features the following companies, which we identified to be key players in this domain:
 BioLinker
 biotechrabbit
 CellFree Sciences
 Creative Biolabs
 CUSABIO
 Daicel Arbor Biosciences
 LenioBio
 Promega
 Thermo Fisher Scientific
 Touchlight

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape: Cell Free Expression Service Providers

5. Market Landscape: Cell Free Expression Kits

6. Cell Free Expression Service Providers: Company Competitiveness Analysis

7. Cell Free Expression Kits: Product Competitiveness Analysis

8. Company Profiles: Cell Free Expression Service Providers

9. Company Profiles: Cell Free Expression Kit Providers

10. Partnerships And Collaborations

11. Funding And Investment Analysis

12. Patent Analysis

13. Market Forecast And Opportunity Analysis

16. Appendix 1: Tabulated Data

17. Appendix 2: List Of Companies And Organizations

For additional details, please visit https://www.rootsanalysis.com/....reports/cell-free-ex

Learn from experts: do you know about these emerging industry trends?
Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities
Investment Opportunities in Women’s Digital Health

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#cellfreeexpressionmarkettrends #cellfreeexpressionmarketgrowth #cellfreeproteinexpressionsystem #biomanufacturing #cellfreeexpressionsystem